Raymond James restated their outperform rating on shares of Colgate-Palmolive (NYSE:CL – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. Raymond James currently has a $105.00 price target on the stock, down from their previous price target of $110.00.
Other equities analysts also recently issued reports about the company. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. Barclays lowered their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Finally, TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $101.16.
Read Our Latest Research Report on CL
Colgate-Palmolive Stock Performance
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the business earned $0.87 EPS. As a group, equities research analysts predict that Colgate-Palmolive will post 3.74 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.
Institutional Investors Weigh In On Colgate-Palmolive
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive in the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $32,000. Hager Investment Management Services LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $36,000. Finally, Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $42,000. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Where Do I Find 52-Week Highs and Lows?
- 3 Must-Have ETFs Set to Dominate This Quarter
- Top Biotech Stocks: Exploring Innovation Opportunities
- Seeking Stability? These 3 Stocks Offer Strong Potential
- What Are Dividend Challengers?
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.